The Business Research Company’s Anti-Thyroid Drugs Global Market Report 2019 covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Explore Complete Report “Anti-Thyroid Drugs Global Market 2019” at https://www.thebusinessresearchcompany.com/report/anti-thyroid-drugs-global-market-report
Ratios of market size and growth to related markets, GDP proportions, and expenditure per capita for the market is detailed in the report. Data and analysis throughout the report is sourced using end notes.
The global anti-thyroid drugs market was valued at about $2.46 billion in 2018 and is expected to grow to $2.79 billion at a CAGR of 3.2% through 2022.
Major Key competitive players in the global Anti-Thyroid Drugs market report include Mylan N.V., Abbott Laboratories, GlaxoSmithKline plc, Merck & Co. and AbbVie Inc.
The anti-thyroid drugs market is a segment of the pharmaceuticals market. The report will answer questions such as where the largest and fastest growing market is, how the market relates to the overall economy, demography and other similar markets, and what forces will shape the market going forward.
Request to get the sample of this report https://www.thebusinessresearchcompany.com/sample.aspx?id=2447&type=smp
The anti-thyroid drugs market consists of sales of anti-thyroid drugs and related services which are used for the treatment of hyperthyroidism. Hyperthyroidism is caused by over production of thyroid hormones in children, adults and pregnant women. Anti-thyroid class of drugs are also called thionamides which block the formation of thyroid hormone from over active thyroid gland.
List of Tables from the Report:
Table 1: Global Historic Market Growth, 2014-2018, $ Billion
Table 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion
Table 3: Global Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
Table 4: Global Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
Table 5: Global Anti-Thyroid Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
Table 6: Global Anti-Thyroid Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
.
.
Table 44: Africa, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
Table 45: Mylan N.V. Financial Performance
Table 46: Abbott Laboratories Financial Performance
Table 47: GlaxoSmithKline plc Financial Performance
Table 48: Merck & Co. Financial Performance
Table 49: AbbVie, Inc. Financial Performance
For latest press releases visit https://www.thebusinessresearchcompany.com/press-release.aspx
About Us:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
No comments:
Post a Comment